Company page

Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc. is a public company traded on the American market under the ticker ARCT. The company has a market capitalization of approximately $157.18 million. Arcturus focuses on developing innovative RNA medicines for various diseases.

ARCT:NASDAQUpdated August 28, 2026
Arcturus Therapeutics Holdings Inc. logo
Ticker
ARCT:NASDAQ
Asset type
Stock
Market cap
$431.7M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD